It’s good to talk, says Europe’s ambitious regulator
February 12, 2004Europe's medicines regulator has unveiled its new long-term strategy to improve its work on human medicines as it prepares to …
War of words over atypicals link to diabetes
February 5, 2004Pfizer and Eli Lilly have tried to distance their products from renewed claims that atypical antipsychotics are linked to an …
Strong Roche says no to mergers
February 5, 2004Roche is set for a strong return to growth in 2004 and says it should be counted out of growing …
AZ switches Symbicort agency
February 5, 2004AstraZeneca has taken on a new PR agency to spearhead a new two-year communications campaign for its respiratory brand treatment …
Zeltia to press ahead with rejected cancer drug
February 4, 2004Zeltia has unveiled a three-year business plan to put itself back on track after lead cancer drug Yondelis was rejected …
Industry chair for communications body
February 3, 2004Stuart Rose has been named as the new chair of the Healthcare Communications Association (HCA), the first ever from the …
AstraZeneca emerges unscathed from $2.6 billion patent loss
February 3, 2004Strong growth in a new generation of products has helped AstraZeneca earn a memorable victory in overcoming $2.6 billion worth …
Managing medical education
February 3, 2004Over the years, Medical Education (med ed) and PR agencies have been an invaluable part of the marketing mix. Med …
Sanofi makes takeover bid for ‘weakened’ Aventis
January 26, 2004Sanofi-Synthelabo has made a pre-emptive E47 billion takeover bid for Aventis with the aim of creating the world's third-biggest drugmaker …
Pfizer takes giant step forward
January 23, 2004The pharmaceutical industry's biggest company Pfizer has restated its dominance with renewed growth in sales and earnings for the fourth …
Abbott raises sales expectations for Humira
January 21, 2004Abbott Laboratories has raised its sales forecast for Humira, its new rheumatoid arthritis treatment, to $700 million in 2004 after …
Pfizer to sell diagnostics business
January 21, 2004Pfizer has agreed to sell its Swedish in-vitro allergy and autoimmune diagnostic business to private equity groups Triton and PPM …
Aventis and Sanofi attempt to quash merger rumours
January 19, 2004Sanofi-Synthelabo and Aventis have been forced to officially deny they are in merger talks after speculation sent shares soaring in …
Streamlined research
January 19, 2004For many years the pharmaceutical industry has been promising that they were on the verge of a boom in the …
Sizing up med ed
January 19, 2004The use of medical education in the pharmaceutical industry has never been greater. Starting from the early stages of clinical …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
